Hosted on MSN1y
Lupin Receives Approval From USFDA For Febuxostat TabletsThe product will be manufactured at Lupin’s Pithampur facility in India. Febuxostat Tablets, 40 mg and 80 mg, are indicated for the chronic management of hyperuricemia in adult patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback